EUVIMEDEUVIMED entdecken
Crossref

Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair

Ryann A Joseph iD, Rebecca M Haley iD, Marshall S Padilla iD, Adele S Ricciardi, Hannah M Yamagata iD, Michael J Mitchell iD

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.5c03548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Ryann A Joseph und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, CRISPR-Cas Systems, CRISPR-Associated Protein 9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: American Cancer Society Research Scholar Grant, NSF CAREER Award, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are currently one of the most clinically advanced delivery systems for nucleic acid cargo and hold great potential for clinical applications in gene editing and the treatment of genetic diseases. LNP-mediated delivery of Cas9 with single guide RNA (sgRNA) and homology-directed repair DNA template (ssDNA) enables efficient and precise editing in vitro and in vivo. Comparative analysis of LNP delivery of Cas9 as protein or mRNA for relevant clinical targets, such as cystic fibrosis (CF), which is caused by mutations in the CFTR gene, is imperative in the design of corrective therapeutics for genetic diseases. Here, we show that delivery of Cas9 protein LNPs outperforms Cas9 mRNA LNPs when evaluated for in vivo lung editing as well as corrective CRISPR/Cas9 editing and functional recovery of the CFTR protein. These results demonstrate the ability to optimize the use of CRISPR/Cas9 LNPs for cystic fibrosis applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisCRISPR-Cas SystemsCRISPR-Associated Protein 9NanoparticlesRNA, MessengerLipidsGene EditingHumansAnimalsRNA, Guide, CRISPR-Cas SystemsMiceLiposomes

Stichwörter der Autor:innen

CRISPR/Cas9 editingcystic fibrosislipid nanoparticleslung delivery

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCRISPR-Associated Protein 9RNA, MessengerCFTR protein, humanRNA, Guide, CRISPR-Cas SystemsLipid NanoparticlesLipidsLiposomes

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Center for Fetal Research, Division of General, Thoracic, and Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
  • Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Abramson Cancer Center, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Immunology, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
  • Cardiovascular Institute, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Ryann A Joseph, Rebecca M Haley, Marshall S Padilla, Hannah M Yamagata, Michael J Mitchell

Förderung

  • American Cancer Society Research Scholar Grant
  • NSF CAREER Award
  • Cystic Fibrosis Foundation
  • National Science Foundation Graduate Research Fellowship Program
  • University of Pennsylvania
  • National Institute of Dental and Craniofacial Research
  • Center for Undergraduate Research and Fellowships, University of Pennsylvania
  • American Cancer Society

Zitieren

APA

Joseph, R. A., Haley, R. M., Padilla, M. S., Ricciardi, A. S., Yamagata, H. M., & Mitchell, M. J. (2025). Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c03548

Vancouver

Joseph RA, Haley RM, Padilla MS, Ricciardi AS, Yamagata HM, Mitchell MJ. Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c03548

BibTeX
@article{Joseph2025,
  author = {Joseph, Ryann A and Haley, Rebecca M and Padilla, Marshall S and Ricciardi, Adele S and Yamagata, Hannah M and Mitchell, Michael J},
  title = {Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.5c03548}
}
Kostenlos starten →